🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 18 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/06/2014 33,13 33,30 32,00 32,20 -2,66% 3,92% 809.600
11/06/2014 32,88 33,80 32,70 33,08 -0,18% 3,35% 602.800
10/06/2014 34,20 34,57 32,95 33,14 -4,08% 4,74% 1.052.500
09/06/2014 34,42 35,23 34,06 34,55 -0,06% 3,40% 970.400
06/06/2014 34,25 34,63 33,76 34,57 +1,50% 2,54% 886.100
05/06/2014 32,86 34,45 32,77 34,06 +4,22% 5,11% 1.094.500
04/06/2014 32,00 32,78 31,16 32,68 +1,52% 5,06% 807.700
03/06/2014 32,87 32,99 31,97 32,19 -2,69% 3,10% 961.200
02/06/2014 33,62 34,12 32,46 33,08 -1,78% 4,94% 579.100
30/05/2014 34,53 34,78 33,18 33,68 -2,91% 4,63% 1.293.400
29/05/2014 34,16 35,01 33,80 34,69 +1,79% 3,54% 1.136.200
28/05/2014 34,74 35,41 33,92 34,08 -2,29% 4,29% 903.500
27/05/2014 34,71 35,43 33,89 34,88 +2,47% 4,44% 1.230.100
23/05/2014 34,54 35,45 33,60 34,04 +4,58% 5,36% 2.304.600
22/05/2014 32,65 33,74 31,89 32,55 +4,53% 5,67% 1.601.000
21/05/2014 31,19 31,63 30,44 31,14 +0,65% 3,82% 972.600
20/05/2014 31,47 32,00 30,31 30,94 -2,18% 5,37% 803.000
19/05/2014 31,12 32,10 31,06 31,63 +0,67% 3,34% 922.700
16/05/2014 32,32 32,94 30,90 31,42 -2,96% 6,31% 861.700
15/05/2014 32,41 32,94 31,33 32,38 -0,95% 4,97% 925.300
14/05/2014 33,76 34,57 32,63 32,69 -4,02% 5,75% 1.083.900
13/05/2014 32,60 34,34 32,45 34,06 +4,67% 5,80% 1.776.100
12/05/2014 32,17 33,86 32,17 32,54 +1,47% 5,25% 1.362.200
09/05/2014 31,05 32,43 30,48 32,07 +3,12% 6,28% 1.226.300
08/05/2014 34,43 34,80 30,71 31,10 -9,28% 11,88% 2.356.900
07/05/2014 35,82 35,82 33,50 34,28 -4,22% 6,48% 1.650.100
06/05/2014 36,24 36,47 35,43 35,79 -2,27% 2,87% 671.200
05/05/2014 35,68 36,78 35,00 36,62 +1,50% 4,99% 653.800
02/05/2014 36,82 36,94 35,77 36,08 -2,17% 3,18% 831.700
01/05/2014 37,24 38,24 36,50 36,88 -0,67% 4,67% 978.600